Related references
Note: Only part of the references are listed.Ghrelin Receptor Signaling: A Promising Therapeutic Target for Metabolic Syndrome and Cognitive Dysfunction
Wei-na Cong et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2010)
PYY3-36 and Oxyntomodulin Can Be Additive in Their Effect on Food Intake in Overweight and Obese Humans
Benjamin C. T. Field et al.
DIABETES (2010)
Elevated hypothalamic orexin signaling, sensitivity to orexin A, and spontaneous physical activity in obesity-resistant rats
J. A. Teske et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2006)
PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity
Niels Vrang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2006)
Prevalence of overweight and obesity in the United States, 1999-2004
CL Ogden et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Attenuated peptide YY release in obese subjects is associated with reduced satiety
CW le Roux et al.
ENDOCRINOLOGY (2006)
Peripheral interaction of ghrelin with cholecystokinin on feeding regulation
Y Date et al.
ENDOCRINOLOGY (2005)
Dietary influences on peripheral hormones regulating energy intake: Potential applications for weight management
J Orr et al.
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION (2005)
Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents
S Stock et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats
PK Chelikani et al.
ENDOCRINOLOGY (2005)
Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin
J Korner et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Effects of PYY[3-36] in rodent models of diabetes and obesity
RA Pittner et al.
INTERNATIONAL JOURNAL OF OBESITY (2004)
Does gut hormone PYY3-36 decrease food intake in rodents?
M Tschöp et al.
NATURE (2004)
Biology of eating behavior in obesity
GJ Schwartz
OBESITY RESEARCH (2004)
Enhancement of feeding suppression by PYY3-36 in rats with area postrerna ablations
JE Cox et al.
PEPTIDES (2004)
Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos expression
T Riediger et al.
NEUROENDOCRINOLOGY (2004)
Inhibition of food intake in obese subjects by peptide YY3-36
RL Batterham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Abnormalities of leptin and ghrelin regulation in obesity-prone juvenile rats
BE Levin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
Ghrelin, an orexigenic signaling molecule from the gastrointestinal tract
M Kojima et al.
CURRENT OPINION IN PHARMACOLOGY (2002)
Gut hormone PYY3-36 physiologically inhibits food intake
RL Batterham et al.
NATURE (2002)
Food fails to suppress ghrelin levels in obese humans
PJ English et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: Enteric distribution, ontogeny, influence of endocrine, and dietary manipulations
HM Lee et al.
ENDOCRINOLOGY (2002)
A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans
DE Cummings et al.
DIABETES (2001)
Post-prandial decrease of circulating human ghrelin levels
M Tschöp et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2001)
A role for ghrelin in the central regulation of feeding
M Nakazato et al.
NATURE (2001)
Share Paper
